Fat, Obesity,
Diabetes and Supplements
Part I

by Dr. Emmanuel
Opara
Click
Here to Read Part II
Type 2 diabetes constitutes
more than 90% of all cases of diabetes mellitus. As many as 80% of individuals
with type 2 diabetes are overweight or obese and obesity often precedes the
development of diabetes. The development of obesity and insulin resistance
depends on a complex interaction between genetic background and diet. Studies
have shown that dietary fat is the primary nutritional stimulus for the
development of obesity and the associated type 2 diabetes. Despite these
findings, consumers are ambivalent towards fat in their foods. To help prevent
the deleterious effects of fat consumption, people suffering from diabetes,
those who are at risk such as persons with family history, and aged
individuals who are deficient in antioxidants, would derive benefits by using
appropriate doses of such supplements as vitamins C and E, L-glutamine,
taurine, chromium and possibly ubiquinone and gymnema sylvestre. The mechanism
of action and the effective doses of these supplements will be discussed in
part II of this article.
Diabetes
As early as 1936, Himsworth observed that diabetes mellitus, which is
characterized by high blood sugar levels, comprises two groups of patients;
those who are insulin sensitive and others who are insulin resistant. It is
now recognized that there are two major types of diabetes viz: type 1 diabetes
or insulin -dependent diabetes mellitus (IDDM) and type 2 diabetes or
non-insulin-dependent diabetes mellitus (NIDDM). The primary defect in type 1
diabetes resides in the pancreas, resulting in insulin deficiency and
concomitant failure to metabolize glucose. In contrast, the problem in type 2
diabetes is predominantly attributable to the inability of the available
insulin to work properly and this type of diabetes involves multiple organ
systems, including abnormalities of insulin secretion, peripheral (muscle and
adipose tissue) and hepatic insulin resistance. Most individuals with type 2
diabetes also suffer from excess body weight or obesity. Indeed, it has been
reported that as many as 80% of NIDDM patients are overweight. Obesity often
precedes type 2 diabetes and is now recognized as a major risk factor for the
development of type 2 diabetes which constitutes more than 90% of all cases of
diabetes mellitus1. This easily translates to a staggering number of persons
with type 2 diabetes. In 1993, it was estimated that about 7.8 million
Americans had diabetes, with type 2 comprising 95% of this number1. In
addition to the diagnosed cases of type 2 diabetes, it is estimated that there
is, at least, one undiagnosed case of type 2 diabetes for every diagnosed
case, based on oral glucose tolerance testing in the second National Health
and Nutrition Examination Survey (NHANES II).(1) Therefore, because of its
preponderance and its relationship to obesity, type 2 diabetes will be the
subject of this review.
Diabetes mellitus is a chronic
and potentially disabling disease which represents a major public health and
clinical concern.(2) Individuals suffering from diabetes are at an increased
risk of developing chronic complications related to ophthalmic, renal,
neurological, cerebrovascular, cardiovascular, and peripheral vascular
diseases. Consequently, people with diabetes are more likely than those
without the disease to have heart attacks, strokes, amputations, kidney
failure and blindness.(2) Furthermore, as a result of diabetes and its
complications, persons with diabetes have more frequent and intensive
encounters with the health-care system. In 1987, the economic costs of
diabetes was estimated at $20.4 billion, of which 47% were direct medical
expenditures. This estimate included some costs associated with chronic
complications of diabetes but excluded the costs of surgical procedures, home
health care, emergency rooms, ambulance services, services provided by
licensed dietitians, physical therapy and costs associated with the late
complications of diabetes. (2)
Prevention & Treatment
It is, therefore, imperative that healthy individuals should adopt effective
strategies to prevent the development of diabetes and for individuals with the
disease to seek beneficial ways to help treatment in order to avoid its
devastations. As already pointed out, the overwhelming majority of cases of
diabetes is NIDDM. Two major factors that play prominent roles in the
development of type 2 diabetes are an individual's genetic predisposition and
environmental influence such as lifestyle including dietary habits. In this
two-part article, the role played by nutrients in the development of type 2
diabetes will be highlighted in the first part. In the second part, the focus
will be on how the use of appropriate supplements can prevent the development
of diabetes in individuals with family history of this disease and others at
high risk, such as elderly people. Also, the use of supplements can positively
affect the clinical course of the disease in those already suffering from type
2 diabetes and this will be discussed in part II .
In a carefully designed study,
the differential effects of fat and sucrose (carbohydrate) on the development
of obesity and diabetes have been examined. (3) In the study, diabetes-prone
C57BL/6J (B/6J) mice and diabetes-resistant A/J mice were fed one of four
different diets, namely: a) high-fat, high-sucrose diet, b) high-fat,
low-sucrose diet, c) low-fat, high-sucrose diet, d) low-fat, low-sucrose diet.
After four months on these diets, it was found that B/6J mice gained more
weight on both high-fat diets without consuming more calories than A/J mice.
In the absence of fat, sucrose caused a decrease in body weight gain in both
strains. Furthermore, whereas fat induced the development of insulin
resistance characterized by hyperglycemia and hyperinsulinemia, sucrose had no
effect on blood glucose and insulin levels.(3) These data clearly show that
the development of obesity and insulin resistance depends on a complex
interaction between genetic background and diet. In other studies performed in
both humans and animal models, it has also been shown that fat is a primary
nutritional stimulus for the development of obesity and the associated type 2
diabetes. Thus, the high content of fat in most Western diets accounts for the
increased incidence of both obesity and diabetes in these populations. Any
diet whose fat content equals or exceeds 30% of total calories should be
considered high. However, consumers have an ambivalent attitude towards fat in
their foods. The reason for this is, although high-fat consumption is
associated with increased risk for obesity, diabetes and other diseases such
as heart disease, fatty foods are known to make meals more palatable. The
stability over years in fat intake suggests that consumers are unwilling to
sacrifice the pleasure of eating fatty foods for health reasons.(4) A sensible
compromise could be achieved under these circumstances if consumers are aware
of nutritional supplements that would help to prevent the development of
deleterious metabolic effects of dietary fat.
Oxidative stress &
diabetic complications
Over three decades ago, Randle and colleagues proposed the "glucose-fatty
acid cycle" hypothesis to explain the link between insulin resistance
associated with type 2 diabetes and obesity. According to this hypothesis,
excessive free fatty acid (FFA) release from adipose tissue for oxidation in
muscle causes the production of metabolites that inhibit glucose utilization
by the muscle. The metabolites identified at the time of Randle's report were
all intermediates of the mitochondrial Krebs tricarboxylic acid cycle, such as
ATP, citric acid and NADH. Recent studies have also shown that increased fatty
acid availability from exogenous sources such as dietary fat, produces the
same results as increased FFA mobilization from endogenous fat deposits.
Furthermore, it is now being recognized that, in addition to the previous
metabolites of fatty acid oxidation implicated in the glucose-fatty acid
cycle, reactive oxygen species which are by -products of fatty acid oxidation
also inhibit glucose metabolism resulting in sugar overload in the blood or
hyperglycemia. It should be pointed out that during periods of increased fatty
acid availability such as during high-fat feeding, there is increased
peroxisomal fatty acid oxidation, mostly due to increased activity of the
enzyme, catalase, a reaction that leads to excessive generation of hydrogen
peroxide. Also, dietary fat may become rancid or undergo lipid peroxidation
leading to the production of increased levels of lipid peroxides. These
peroxides are reactive oxygen species which cause damage to cellular
structures and impair glucose metabolism. Under normal circumstances, there is
a delicate balance between reactive oxygen species (free radical) production
and the levels of antioxidant defense mechanisms in the body. During periods
of increased reactive oxygen species production, the antioxidant defense
systems used by the body for detoxification, become overwhelmed. This results
in the presence of toxic levels of reactive oxygen species which oxidize and
inhibit the heme-containing glyceraldehyde-3-phosphate dehydrogenase enzyme of
the glycolytic pathway and the cytochrome enzymes of the electron transport
chain responsible for oxidative phosphorylation associated with Krebs cycle.
The consequence of these inhibitory effects of reactive oxygen species on the
enzymes involved in glucose oxidation is the development of hyperglycemia.
Simultaneously, fatty acid oxidation by the pancreatic islets of Langerhans
causes increased insulin output(5) that results in hyperinsulinemia. In this
way, fat metabolism produces insulin resistance which precedes the development
of clinical type 2 diabetes. In addition to the outlined role of reactive
oxygen species in the pathogenesis of type 2 diabetes, the relationship
between oxidative stress (increased free radical generation in the presence of
reduced antioxidant availability) and diabetic complications has been
extensively studied. In general, oxidative stress has been implicated in the
development of both macro- and micro-vascular complications of diabetes.
Dietary factors
The studies performed by Surwit and colleagues showed that although sucrose in
the presence of low-fat caused an apparent decrease in body weight and had no
effect on plasma insulin and glucose levels in the obesity- and diabetes-prone
B /6J mice, the addition of this carbohydrate to a high-fat diet did
exacerbate increases in body weight, plasma insulin and glucose levels induced
by fat. This observation may be explained by the fact that some metabolites of
fatty acid oxidation enhance endogenous glucose production by the liver in the
face of reduced glucose utilization in the body caused by other metabolites
and products of fatty acid oxidation. Also, high carbohydrate diets have been
shown to stimulate lipogenesis and this phenomenon in the presence of abundant
dietary fat would enhance fat storage and body weight gain. A zero percent fat
diet is unrealistic and even if such a diet were to be formulated with very
high content of carbohydrate, it would induce hyperlipidemia which over time
may lead to metabolic abnormalities. The combined effect of fat and sucrose
represents more closely the real life situation since most human diets
comprise fat, carbohydrate and other nutrients in different proportions. This
situation, therefore, demands the need for supplements that would take care of
the unwanted side-effects of fat consumption.
The study by Surwit and
colleagues showed that diet did not affect plasma glucose and insulin levels
in A/J mice but high-fat diets induced significant gains in body weight in
this diabetes-resistant mouse strain. This observation may explain why some
individuals gain significant body weight without developing diabetes. Type 2
diabetes is known to have a familial aggregation and studies of twins and
offsprings of diabetic patients have provided a strong evidence for a role of
the genetic component in the development of this disease.6 Although there is
good evidence that type 2 diabetes may be determined by major genes in high
-risk individuals, a polygenic mode of inheritance may not be responsible for
glucose intolerance. In spite of increased search, no single specific marker
for type 2 diabetes has yet been found but linkage in some families has been
discovered.(6)
The incidence of diabetes
increases with age. Impaired glucose tolerance (IGT) is clearly the first
recognized stage in the development of type 2 diabetes and it has been
reported that the prevalence of IGT reaches 23% at ages 65-74 years in the US
population.(6) The are several reasons to explain the increased incidence of
type 2 diabetes with age. First, aging appears to induce a specific defect in
glucose-stimulated insulin secretion. This defect is an aspect of the global
defect in glucose metabolism that generally occurs with aging and this has
been attributed to multiple postbinding defects (including glucose transport)
after insulin binding to its receptor. Second, abnormalities in insulin
regulation of FFA /lipid metabolism secondary to increased fat mass and
substrate competition between fat and glucose are present and appear to play a
role in insulin resistance of human aging. Third, antioxidant defense systems
are reduced with age. To prevent these changes that occur with aging, the need
for supplements is apparent. Among the beneficial supplements for disease
prevention are: antioxidants such as ubiquinone, vitamins C and E; supplements
that enhance tissue antioxidant levels such as L-glutamine; other supplements
that inhibit fatty acid oxidation such as L-glutamine and taurine, as well as
those such as L-glutamine and chromium which promote blood glucose regulation
through the reduction of body weight. In addition, the use of antioxidant
supplements may also prevent the development of other age-associated diseases.
Summary
People suffering from diabetes, those who are at risk such as persons with
family history, and aged individuals who are known to be deficient in
antioxidant defense systems, would derive benefits by using appropriate doses
of antioxidant supplements, such as vitamins C and E, and other supplements,
such as L -glutamine and taurine which inhibit excessive fatty acid oxidation.
Chromium supplement available as chromium picolinate has been found to be
useful for weight loss and for blood sugar control. Lesser known supplements
such as ubiquinone and gymnema sylvestre have also been reported to be
efficacious in both prevention and treatment of diabetes. The mechanism of
action and effective doses of these supplements will be discussed at great
length in the second part of this
article.
Highly recommended
source of nutrients and supplements.
How did we qualify VRP?
Dr. Emmanuel C. Opara is a
research professor in the Departments of Surgery and Cell Biology and is a
member of the Sara W. Stedman Center for Nutritional Studies at Duke
University Medical Center in Durham North Carolina.